New study sheds light on pregnancy risks for women with rare immune disorders
NCT ID NCT04581460
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 99 women with primary immune deficiency to learn more about their pregnancies and birth outcomes. Researchers tracked infections during pregnancy and after birth, as well as how well contraception worked. The goal is to help doctors give better advice to women with these rare immune conditions who want to have children.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better medical guidelines for managing pregnancy and contraception in women with primary immune deficiency.
- What could go wrong
- This is an observational study using questionnaires, not a treatment trial. It cannot prove what works best, only describe what happened.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Necker-Enfants Malades
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a stool sample replace a spinal tap? new study tests Non-Invasive infection detection
- Massive new registry aims to unlock secrets of biologic drugs
- Scientists hunt for genetic clues to mysterious immune diseases
- New shot could help Immune-Compromised patients fight infections
- Blood cell harvest could fuel future immune disease cures